Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01206075 |
|
Recruitment Status :
Completed
First Posted : September 21, 2010
Last Update Posted : December 30, 2014
|
Sponsor:
University of Washington
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
George Papanicolaou Hospital
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Thalia Papayannopoulou, University of Washington
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 2012 |
| Actual Study Completion Date : | December 2014 |